-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to Q3 2025.
- Apellis Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2025 was 7.91 %.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2024 was -21.1 %, a 83.8% increase from 2023.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2023 was -130 %, a 83.5% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2022 was -788 %, a 2.15% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)